Cargando…
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side effect of chemotherapy with poorly understood mechanisms and few treatments. High-mobility group box 1 (HMGB1)-induced neuroinflammation is the main cause of CIPN. Here, we aimed to illustrate the role of the macrophage...
Autores principales: | Yang, Xing, Jia, Rumeng, Hu, Fan, Fan, Wen, Lin, Tongtong, Zhang, Xiaotao, Xu, Chenjie, Ruan, Shirong, Jiang, Chunyi, Li, Yan, Pan, Cailong, Yang, Yang, Hu, Liang, Chen, Qi, Liu, Wen-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161452/ https://www.ncbi.nlm.nih.gov/pubmed/37143083 http://dx.doi.org/10.1186/s12964-023-01100-9 |
Ejemplares similares
-
Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
por: Sekiguchi, Fumiko, et al.
Publicado: (2020) -
Epac1 Requires AMPK Phosphorylation to Regulate HMGB1 in the Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2020) -
The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis
por: Cao, Shirong, et al.
Publicado: (2013) -
NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy
por: Lin, Tongtong, et al.
Publicado: (2022) -
Hydrogen attenuates postoperative pain through Trx1/ASK1/MMP9 signaling pathway
por: Li, Juan, et al.
Publicado: (2023)